Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2012
11/29/2012US20120301449 Rna interference target for treating aids
11/29/2012US20120301447 TRUNCATED EPIDERIMAL GROWTH FACTOR RECEPTOR (EGFRt) FOR TRANSDUCED T CELL SELECTION
11/29/2012US20120301438 Reprogramming Blood Cells to Pluripotent and Multipotent Stem Cells
11/29/2012US20120301434 Antibacterial polypeptides and use thereof
11/29/2012US20120301429 Dac hyp compositions and methods
11/29/2012US20120301428 Clostridium gene
11/29/2012US20120301395 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
11/29/2012US20120301393 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin
11/29/2012DE602004036672C5 Nukleinsäureamplifikation auf Basis von Kügelchenemulsion Nucleic acid amplification-based emulsion globules
11/29/2012DE112010004584T5 Chimäre Endonukleasen und Anwendungen davon Chimeric endonucleases and applications thereof
11/29/2012DE112010004582T5 Optimierte Endonukleasen und Anwendungen davon Optimized endonucleases and applications thereof
11/29/2012DE112010000838T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Plants having enhanced yield-related traits and methods of making the same
11/29/2012DE112009004267T5 Rekombinantes Antigen für den Nachweis vonToxokarose The recombinant antigen for the detection vonToxokarose
11/29/2012CA2837346A1 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
11/29/2012CA2837322A1 Cell and gene based methods to improve cardiac function
11/29/2012CA2837170A1 Modular transport platform for targeted delivery of therapeutic agents
11/29/2012CA2837126A1 Canine influenza recombinant virus, preparation method therefor and application thereof
11/29/2012CA2837000A1 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
11/29/2012CA2836898A1 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
11/29/2012CA2836815A1 Plants having enhanced abiotic stress resistance
11/29/2012CA2836775A1 Chloroplast transit peptides and methods of their use
11/29/2012CA2836711A1 Bilirubin oxidase from magnaporthe oryzae and applications thereof
11/29/2012CA2836649A1 Anti-cgrp compositions and use thereof
11/29/2012CA2836364A1 Erk inhibitors for use in treating spinal muscular atrophy
11/29/2012CA2835222A1 Transgenic chicken comprising an inactivated immunoglobulin gene
11/29/2012CA2835170A1 Development of phytophthora resistant potato with increased yield
11/29/2012CA2834716A1 Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi
11/29/2012CA2834584A1 Fgfr-fc fusion protein and use thereof
11/29/2012CA2834442A1 Immunostimulatory oligodeoxynucleotides
11/29/2012CA2834440A1 Immunostimulatory oligodeoxynucleotides
11/29/2012CA2831161A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
11/28/2012EP2527457A1 Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
11/28/2012EP2527456A1 Transgenic porcines lacking endogenous immunoglobulin light chain
11/28/2012EP2527455A2 Vegetabile material, plants and a method of producing a plant having altered lignin properties
11/28/2012EP2527454A1 Vegetabile material, plants and a method of producing a plant having altered lignin properties
11/28/2012EP2527453A2 Chloroplast transit peptides for efficient targeting of DMO and uses thereof
11/28/2012EP2527452A2 Chloroplast transit peptides for efficient targeting of DMO and uses thereof
11/28/2012EP2527451A1 Screening method for identifying genes involved in plant cell cycle
11/28/2012EP2527450A1 Plant root-specific nematode resistance
11/28/2012EP2527449A2 Methods involving genes encoding nucleoside diphosphatase kinase (NDK) polypeptides and homologs thereof for modifying the plant's root architecture
11/28/2012EP2527448A1 Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi
11/28/2012EP2527447A1 Agents and methods for diagnosing stress
11/28/2012EP2527446A1 Agents and methods for diagnosing stress
11/28/2012EP2527445A2 Treatment and prevention of influenza
11/28/2012EP2527444A2 Antisense oligonucleotide modulation of stat3 expression
11/28/2012EP2527443A2 RNAi-mediated inhibition of IGF-1R for treatment of ocular angiogenesis
11/28/2012EP2527442A2 Compounds and methods for modulating gene expression
11/28/2012EP2527441A2 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
11/28/2012EP2527440A1 Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
11/28/2012EP2527439A2 Compositions and methods related to mRNA translational enhancer elements
11/28/2012EP2527438A1 Methods and compositions for DNA fragmentation and tagging by transposases
11/28/2012EP2527437A1 Novel anti-CD98 antibody
11/28/2012EP2527436A1 Nadh oxidase mutant having improved stability and use thereof
11/28/2012EP2527435A2 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT 8) gene expression
11/28/2012EP2527434A1 Probe reagent for measurement of protein decomposition activity
11/28/2012EP2527433A1 Foreign gene transfer method by electroporation technique
11/28/2012EP2527432A1 Bi-directional cytosine deaminase-encoding selection marker
11/28/2012EP2527430A2 Method of preparing a dough-based product
11/28/2012EP2527369A2 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
11/28/2012EP2527367A1 Production method
11/28/2012EP2527362A1 Nucleic acid molecules encoding wrinkled1-like polypeptides and methods of use in plants
11/28/2012EP2527354A1 Compositions and methods for inhibiting expression of Eg5 gene
11/28/2012EP2526968A2 Nogo receptor antagonists
11/28/2012EP2526953A1 Methods and pharmaceutical compositions for healing wounds
11/28/2012EP2526952A1 Methods and pharmaceutical compositions for healing wounds
11/28/2012EP2526207A2 Compositions and methods for gene signature - based chemical screening
11/28/2012EP2526199A2 Methods of generating zinc finger nucleases having altered activity
11/28/2012EP2526194A1 Methods for intracellular delivery of nucleic acids
11/28/2012EP2526193A1 Methods and compositions for displaying a polypeptide on a yeast cell surface
11/28/2012EP2526192A2 Methods of generating modified polynucleotide libraries and methods of using the same for directed protein evolution
11/28/2012EP2526191A1 Method for isolating small rna
11/28/2012EP2526119A2 Engineered opsonin for pathogen detection and treatment
11/28/2012EP2525909A1 Consumable analytical plasticware comprising high-solubility plastics
11/28/2012EP2525818A2 Immunogenic influenza composition
11/28/2012EP2525806A1 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity
11/28/2012EP2525651A2 Novel centromeres and methods of using the same
11/28/2012EP2525650A2 Engineered landing pads for gene targeting in plants
11/28/2012EP2525649A2 Excision of transgenes in genetically modified organisms
11/28/2012EP2463368A9 Humanized anti-amyloid-b oligomer antibody
11/28/2012EP2463367A9 Novel ubiquitin ligase and use thereof
11/28/2012EP2453013A9 Treatment of cellulosic material and enzymes useful therein
11/28/2012CN1745173B Genes conferring herbicide resistance
11/28/2012CN1738829B New 2',5'-oligoadenylic acid analog
11/28/2012CN1335394B Generation of L-glutamic acid bacterium and process for producing L-glutamic acid
11/28/2012CN102803508A Composition and method for imaging stem cells
11/28/2012CN102803496A Virus induced gene silencing (VIGS) for functional analysis of genes in cotton
11/28/2012CN102803495A Combined use of Cry1Ca and Cry1Ab proteins for insect resistance management
11/28/2012CN102803494A Rna-mediated Induction Of Gene Expression In Plants
11/28/2012CN102803493A Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG
11/28/2012CN102803492A Treatment Of Tristetraproline (ttp) Related Diseases By Inhibition Of Natural Antisense Transcript To Ttp
11/28/2012CN102803491A Methods and compositions for displaying a poypeptide on a yeast cell surface
11/28/2012CN102803490A Methods, compositions, and kits for recovery of nucleic acids or proteins from fixed tissue samples
11/28/2012CN102803489A Combined automated parallel synthesis of polynucleotide variants
11/28/2012CN102803488A Human artificial chromosome vector
11/28/2012CN102803487A Cancer antigen helper peptide
11/28/2012CN102803486A Novel protein and gene that codes therefor
11/28/2012CN102803485A Modified biotin-conjugated protein
11/28/2012CN102803484A Process for production of protein
11/28/2012CN102803476A Reprogramming blood cells to pluripotent and multipotent stem cells
11/28/2012CN102803470A Engineering the pathway for succinate production